MAYAKU PHARMACEUTICAL DEVELOPMENT (Private limited company)
MAYAKU PHARMACEUTICAL DEVELOPMENT is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0755.350.975. It was founded on 29-09-2020. Its registered office is in Ghent. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 1 291 and a profit of € 1 553. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of MAYAKU PHARMACEUTICAL DEVELOPMENT
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 1 553-68 % | € 4 785 | € -25 490-73 % | € -14 743 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 1 291 | € -262+95 % | € -5 047 | € 20 443 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 170 483+72 % | € 99 127+7 % | € 93 053+57 % | € 59 187 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 104 752+115 % | € 48 711 | € -16 657-40 % | € -11 868 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Ghent.
| Company | Town |
|---|---|
| RNA Pioneering | 9052 Gent |
| Eurofins Amatsigroup | 9052 Gent |
| Taikun Pharmaceutical Technology | 9052 Gent |
| APCOR R&M | 9052 Gent |
| 272BIO | 9052 Gent |
| AVROXA | 9052 Gent |
| ILiAD Biotechnologies | 9052 Gent |
| AnimAb | 9052 Gent |
Frequently asked questions
Is MAYAKU PHARMACEUTICAL DEVELOPMENT still active? Yes. The Crossroads Bank for Enterprises lists MAYAKU PHARMACEUTICAL DEVELOPMENT as active.
What is the VAT number of MAYAKU PHARMACEUTICAL DEVELOPMENT? The VAT number of MAYAKU PHARMACEUTICAL DEVELOPMENT is BE 0755.350.975.
When was MAYAKU PHARMACEUTICAL DEVELOPMENT founded? MAYAKU PHARMACEUTICAL DEVELOPMENT was founded on 29-09-2020.
What is the address of MAYAKU PHARMACEUTICAL DEVELOPMENT? The current registered office of MAYAKU PHARMACEUTICAL DEVELOPMENT is Technologiepark-Zwijnaarde 82, 9052 Gand.
When did MAYAKU PHARMACEUTICAL DEVELOPMENT last file annual accounts? The latest annual accounts of MAYAKU PHARMACEUTICAL DEVELOPMENT were filed on 04-07-2026.
Does MAYAKU PHARMACEUTICAL DEVELOPMENT file its annual accounts on time? Yes. MAYAKU PHARMACEUTICAL DEVELOPMENT filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is MAYAKU PHARMACEUTICAL DEVELOPMENT financially healthy? Addrly gives MAYAKU PHARMACEUTICAL DEVELOPMENT a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is MAYAKU PHARMACEUTICAL DEVELOPMENT profitable? The annual accounts of MAYAKU PHARMACEUTICAL DEVELOPMENT for 2025 show a profit of € 1 553.
What is the equity of MAYAKU PHARMACEUTICAL DEVELOPMENT? The equity of MAYAKU PHARMACEUTICAL DEVELOPMENT was € 1 291 at the close of the 2025 financial year.
Who are the directors of MAYAKU PHARMACEUTICAL DEVELOPMENT? The annual accounts of MAYAKU PHARMACEUTICAL DEVELOPMENT record 1 mandate. The name, role and dates are visible with a free account.
Can MAYAKU PHARMACEUTICAL DEVELOPMENT receive Peppol e-invoices? Yes. MAYAKU PHARMACEUTICAL DEVELOPMENT is registered on the Peppol network and can receive structured electronic invoices.
What does MAYAKU PHARMACEUTICAL DEVELOPMENT do? The main activity of MAYAKU PHARMACEUTICAL DEVELOPMENT is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.